Bloomage BioTechnology Corporation Limited (SHA:688363)
37.45
-1.12 (-2.90%)
Aug 14, 2026, 3:00 PM CST
SHA:688363 Revenue
Bloomage BioTechnology Corporation had revenue of 829.41M CNY in the quarter ending March 31, 2026, a decrease of -23.06%. This brings the company's revenue in the last twelve months to 3.95B, down -22.36% year-over-year. In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.20B, down -21.82%.
Revenue (ttm)
3.95B
Revenue Growth
-22.36%
P/S Ratio
4.53
Revenue / Employee
1.07M
Employees
3,698
Market Cap
17.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | -1.17B | -21.82% |
| Dec 31, 2024 | 5.37B | -705.15M | -11.61% |
| Dec 31, 2023 | 6.08B | -283.27M | -4.45% |
| Dec 31, 2022 | 6.36B | 1.41B | 28.53% |
| Dec 31, 2021 | 4.95B | 2.32B | 87.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Hongda Holdings Group | 21.06B |
| Befar Group | 14.98B |
| SKSHU Paint | 12.83B |
| Shandong Dongyue Organosilicon Materials | 3.82B |
| PhiChem | 3.23B |
| Weihai Guangwei Composites | 2.93B |
| Jinhong Gas | 2.82B |
| Xizang Gaozheng Civil Explosives | 1.79B |
Bloomage BioTechnology Corporation News
- 3 months ago - Bloomage BioTechnology Corporation Quarterly report: Q1 2026 - Filings
- 4 months ago - Bloomage BioTechnology Corporation Annual report: Q4 2025 - Filings
- 10 months ago - Bloomage BioTechnology Corporation Quarterly report: Q3 2025 - Filings
- 1 year ago - Bloomage BioTechnology Corporation Quarterly report: Q2 2025 - Filings